Results 21 to 30 of about 189,589 (267)

Angiography of liver transplantation patients [PDF]

, 1985
Over 45 months, 119 angiographic examinations were performed in 95 patients prior to liver transplantation, and 53 examinations in 44 patients after transplantation.
Bron, KM, Gartner, JC, Iwatsuki, S, Malatack, JJ, Shaw, BW, Starzl, TE, Urbach, AH, Van Thiel, DH, Zajko, AB, Zitelli, BJ   +9 more
core   +1 more source

Liver Stiffness Measurements in Patients with Non‐cirrhotic Portal Hypertension – The Devil is In the Details [PDF]

, 2018
Non‐cirrhotic portal hypertension (NCPH) is often a diagnostic challenge due to signs and symptoms of portal hypertension that overlap with cirrhosis. The etiology of NCPH is broadly classified as prehepatic, hepatic (pre‐sinusoidal and sinusoidal) and ...
Chalasani, Naga, Mathur, Karan, Pyko, Maximillian, Samala, Niharika, Vuppalanchi, Raj   +4 more
core   +1 more source

The efficacy and safety of direct oral anticoagulants in noncirrhotic portal vein thrombosis.

Blood Advances, 2020
Guidelines currently favor vitamin K antagonists or low-molecular-weight heparins for treatment of noncirrhotic portal vein thrombosis (ncPVT). Use of direct oral anticoagulants (DOACs) in PVT has been met with concern because of the lack of data.
L. Naymagon, D. Tremblay, N. Zubizarreta, E. Moshier, K. Troy, T. Schiano, J. Mascarenhas   +6 more
semanticscholar   +1 more source

Natural history of patients with non cirrhotic portal hypertension: Comparison with patients with compensated cirrhosis [PDF]

, 2018
Background. The knowledge of natural history of patients with portal hypertension (PH) not due to cirrhosis is less well known than that of cirrhotic patients. Aim.
Aprile, Francesca, Gioia, Stefania, Merli, Manuela, Nardelli, Silvia, Nicoletti, Valeria, Pasquale, Chiara, Pentassuglio, Ilaria, Riggio, Oliviero   +7 more
core   +1 more source

Portal Revascularization in the Setting of Cavernous Transformation Through a Paracholedocal Vein: A Case Report [PDF]

, 2010
Diffuse thrombosis of the entire portal system (PVT) and cavernomatous transformation of the portal vein (CTPV) represents a demanding challenge in liver transplantation.
Bueno, A. (Álvaro), Marti-Cruchaga, P. (Pablo), Pardo, F. (Fernando), Rotellar, F. (Fernando), Valenti, V. (Víctor), Zozaya, G. (Gabriel), Álvarez-Cienfuegos, J. (Javier)   +6 more
core   +1 more source

Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis

Advances in Therapy, 2020
Introduction Benefit and risk of anticoagulation in cirrhotic patients with portal vein thrombosis (PVT) remain controversial, especially in those with asymptomatic PVT and in non-liver transplant candidates.
Le Wang, Xiaozhong Guo, Xiangbo Xu, V. De Stefano, A. Plessier, Carlos Noronha Ferreira, X. Qi   +6 more
semanticscholar   +1 more source

Portal vein thrombosis, mortality and hepatic decompensation in patients with cirrhosis: A meta-analysis [PDF]

, 2015
AIM: To determine the clinical impact of portal vein thrombosis in terms of both mortality and hepatic decompensations (variceal hemorrhage, ascites, portosystemic encephalopathy) in adult patients with cirrhosis.
Cornella, Scott L., Ghabril, Marwan S., Northup, Patrick G., Rudnick, Sean R., Shah, Puja M., Stine, Jonathan G., Stukenborg, George J.   +6 more
core   +1 more source

CAQ Corner: Immune‐mediated complications

, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Efficacy and Safety of Direct-Acting Oral Anticoagulants Use in Acute Portal Vein Thrombosis Unrelated to Cirrhosis [PDF]

, 2017
In acute portal vein thrombosis (APVT) unrelated to cirrhosis, anticoagulant therapy is classically started with low molecular weight heparin or vitamin K antagonists.
De Gottardi, A., Morais, S., Nery, F., Teixeira-Gomes, M., Valadares, D.   +4 more
core   +3 more sources

Von Willebrand and Factor VIII Portosystemic Circulation Gradient in Cirrhosis: Implications for Portal Vein Thrombosis

Clinical and Translational Gastroenterology, 2020
OBJECTIVES: Portal vein thrombosis seems to be dependent on local hypercoagulation and venous stasis; data regarding endothelial damage are lacking.
M. Praktiknjo, J. Trebicka, R. Carnevale, D. Pastori, A. Queck, E. Ettorre, F. Violi   +6 more
semanticscholar   +1 more source